# ScoreItem: Ecodopplercardiograma - FEVE Mulheres

**ID:** `019bf31d-2ef0-7d51-b940-463ab5e89c3e`
**FullName:** Ecodopplercardiograma - FEVE Mulheres (Exames - Imagem)
**Unit:** %
**Gender:** female

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 13 artigos
- Avg Similarity: 0.507

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7d51-b940-463ab5e89c3e`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7d51-b940-463ab5e89c3e",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** Ecodopplercardiograma - FEVE Mulheres (Exames - Imagem)
**Unidade:** %
**G√™nero:** female

**30 chunks de 13 artigos (avg similarity: 0.507)**

### Chunk 1/30
**Article:** Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography (2015)
**Journal:** Journal of the American Society of Echocardiography
**Section:** abstract | **Similarity:** 0.664

Updated guidelines for echocardiographic assessment. Normal LVEF ‚â•54% in women by Simpson method. Sex-specific reference ranges are essential for accurate diagnosis of systolic dysfunction.

---

### Chunk 2/30
**Article:** Sex-Specific Reference Values for Left Ventricular Ejection Fraction in Heart Failure: The MAGGIC Meta-Analysis (2013)
**Journal:** Circulation
**Section:** abstract | **Similarity:** 0.596

Women with heart failure have higher LVEF than men. Sex-specific cutoffs improve HFpEF vs HFrEF classification. Women have better outcomes at equivalent LVEF values compared to men.

---

### Chunk 3/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.547

fortheman-
agementofheartfailure:Areportof
theAmericanCollegeofCardiologyFoundation/AmericanHeartAssociationtaskforceonpracticeguidelines.JAmCollCardiol.2013;62:e147‚Äìe239.3.BealeAL,MeyerP,MarwickTH,LamCSP,KayeDM.Sexdifferencesincardio-vascularpathophysiology:Whywomen
areoverrepresentedinheartfailurewith
preservedejectionfraction.Circulation.2018;138:198‚Äì205.4.ShahKS,XuH,MatsouakaRA,BhattDL,HeidenreichPA,HernandezAF,Devore
AD,YancyCW,FonarowGC.Heartfail-urewithpreserved,borderline,andre-ducedejectionfraction:5-yearout-
comes.JAmCollCardiol.2017;70:2476‚Äì2486.5.HsichEM,Grau-SepulvedaMV,HernandezAF,PetersonED,Schwamm
LH,BhattDL,FonarowGC.Sex
differencesinin-hospitalmortalityinacutedecompensatedheartfailurewithreducedandpreservedejection
fraction.AmHeartJ.2012;163:430‚Äì437.e3.6.CittadiniA,SalzanoA,IacovielloM,TriggianiV,RengoG,CacciatoreF,
MaielloC,LimongelliG,MasaroneD,
PerticoneF,CimellaroA,PerroneFilardiP,PaolilloS,ManciniA,VolterraniM,VrizO,CastelloR,PassantinoA,Campo
M,ModestiPA

---

### Chunk 4/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** results | **Similarity:** 0.539

dline).Patientsaregroupedaccordingtowhethermyocardialinjurywaspresent(red)orabsent(gray).Pairedlog-ranktestresultsarep¬º0.40forwomenwithmyocardialinjuryandp¬º0.08forwomenwithoutmyocardialinjury.JACCVOL.74,NO.16,2019Leeetal.OCTOBER22,2019:2032‚Äì43Sex-SpecicThresholdsofhs-cTnI2039

infarctioninwomenandmen(15).Theimpactofsex-specicthresholdsonthediagnosisofmyocardialinfarctionhasbeenevaluatedinanumberofobser-vationalstudieswithdivergentndings(7,16‚Äì20).Mostofthesestudiesenrolledselectedpatientswith
acutecoronarysyndrome,ofwhomthemajoritywere
men.Furthermore,sex-specicthresholdswerenotusedtoguideclinicalcareorsubsequentinvestiga-
tionforcoronaryarterydisease.Here,weimple-
mentedsex-specicthresholdsintoroutineclinicalcareinarandomizedcontrolledtrialandevaluatedtheirimpactinconsecutivepatientspresentingwith
suspectedacutecoronarysyndrome.Wefoundthat
useofsex-specicthresholdsidentiedproportion-atelymorewomen,suchthattheoverallpercentages
ofwomenandmenidentiedashavingmyocardialinjury

---

### Chunk 5/30
**Article:** Sex Differences in Cardiac Function, Left Ventricular Mass and Ejection Fraction: Insights from the UK Biobank (2017)
**Journal:** European Heart Journal
**Section:** abstract | **Similarity:** 0.537

Sex differences exist in cardiac function. Women have higher LVEF than men (>54% vs >52%), smaller ventricular volumes, and lower mass. These differences persist across age groups and influence heart failure presentation and outcomes.

---

### Chunk 6/30
**Article:** Mastologia II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.516

dos sintomas gerais a investigar em consulta, como dor mam√°ria e TPM intensa, que podem indicar predomin√¢ncia estrog√™nica.

## Objetivo:
N√£o h√° achados de exame f√≠sico de um paciente espec√≠fico. A abordagem objetiva descrita inclui:
- Avalia√ß√£o da composi√ß√£o corporal por bioimped√¢ncia ou densitometria de corpo total, identificando condi√ß√µes como sarcopenia em mulheres com peso normal.
- Solicita√ß√£o de exames laboratoriais para avaliar marcadores inflamat√≥rios e verificar se a paciente est√° metabolicamente doente ou em risco.

## Diagn√≥stico Prim√°rio:
- Avalia√ß√£o: Discuss√£o educacional sobre estratifica√ß√£o de risco para c√¢ncer de mama. 90% dos casos relacionam-se ao estilo de vida e 10% a fatores gen√©ticos conhecidos. Muta√ß√µes de alta penetr√¢ncia (ex.: BRCA1, BRCA2, TP53) aumentam significativamente o risco, por√©m s√£o raras. Epigen√©tica e estilo de vida s√£o cruciais e modific√°veis.

---

### Chunk 7/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.515

il√¢ncia aumentada nas mulheres.**
- Pr√©-menopausa: incid√™ncia de eventos cardiovasculares em mulheres √© muito menor (raz√µes 1:20 a 1:30 versus homens).
- P√≥s-menopausa: aproxima√ß√£o para quase 1:1, refletindo a perda do efeito protetor do estrog√™nio e a mudan√ßa no perfil de risco.
**Additional Key Findings**
- Limiares de exposi√ß√£o/oxida√ß√£o do LDL: acima de 0,8 h√° maior exposi√ß√£o do LDL √† oxida√ß√£o; alvo desej√°vel ‚â§0,7‚Äì0,8.
- Evid√™ncia hist√≥rica (Interarte, 2004) e revis√µes recentes (2023) sustentam a evolu√ß√£o do conhecimento sobre D, resist√™ncia √† insulina e risco cardiovascular.
- Lp(a) tem ~90% de variabilidade gen√©tica, indicando forte determina√ß√£o heredit√°ria e necessidade de estrat√©gias espec√≠ficas.
- Semaglutida em IC diast√≥lica e obesidade: estudo com n=529 mostrou redu√ß√£o de peso de 10% e apenas 1 evento de morte por IC no grupo tratado, sugerindo benef√≠cio cl√≠nico.

---

### Chunk 8/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.513

%CI1.13‚Äì4.50;P=0.02forcardiovascularhospitalization)(TableS1).Similarresultswereobtainedafterexcluding(n=8)patientswithLVEFbetween40and45%(Table2).DiscussionThemainndingsofthecurrentstudyarethat(1)TDishighlyprevalentamongwomenwithHFrEF,around
one-third;(2)whenpresent,TDshapesaclustercharacter-izedbyreducedexercisecapacity,abnormalrightventricular-arterialcouplingandimpairedrenalfunction;(3)
TDhasasignicantimpactonmorbidityandmortalityoffemalepatientsaffectedbyHFrEFbeinganindependent
Testosteronedeciencyinwomenwithheartfailure3ESCHeartFailure(2022)DOI:10.1002/ehf2.14117
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

predictorofall-causemortalityandcardiovascularhospitali-zation.Tothebesttoourknowledge,thisreportistherstaddressingtheimpactofTDinwomenaffectedbyHFrEF.Impactoftestosteronedeciencyonclinicalstatus,morbidity,andmortalityoffemaleHFrEFTheevidenceofapositiveeffectplayedbytestosteroneoncardi

---

### Chunk 9/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** discussion | **Similarity:** 0.511

:1354‚Äì63.22.ThompsonEA,FerrarisS,GressT,FerrarisV.Genderdifferencesandpredictorsofmortalityinspontaneouscoronaryarterydissection:areviewofreportedcases.JInvasiveCardiol2005;17:59‚Äì61.23.SaraJD,WidmerRJ,MatsuzawaY,LennonRJ,LermanLO,LermanA.Prevalenceofcoronary
microvasculardysfunctionamongpatientswith
chestpainandnonobstructivecoronaryartery
disease.JAmCollCardiolIntv2015;8:1445‚Äì53.24.ScottPE,UngerEF,JenkinsMR,etal.Partic-ipationofwomeninclinicaltrialssupportingFDA
approvalofcardiovasculardrugs.JAmCollCardiol2018;71:1960‚Äì9.25.LeeKK,WeltonN,ShahAS,etal.DifferencesinrelativeandabsoluteeffectivenessoforalP2Y12inhibitioninmenandwomen:ameta-analysisandmodellingstudy.Heart2018;104:657‚Äì64.26.SwahnE,AlfredssonJ,AfzalR,etal.Earlyinvasivecomparedwithaselectiveinvasivestrat-
egyinwomenwithnon-ST-elevationacutecoro-
narysyndromes:asubstudyoftheOASIS5trial
andameta-analysisofpreviousrandomizedtrials.

---

### Chunk 10/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.508

en.19Takentogether,extantdatamayrepresentthepathophysiological
underpinningofthereducedpeakoxygenconsumptioninTDHFrEFwomen,consideringthatthemaincomponentofVO2peakarecardiaccontractilityandskeletalmuscleoxygenextraction.20VO2peakisapowerfulpredictorofmortalityinthewholeheartfailurespectrumandisalsothekeyexamina-tiontoselectcandidatesforhearttransplant.21Aneffectoftestosteroneandothersexualhormonesoncardiopulmonaryperformanceofwomenhasbeenalreadyhypothesized22andisrootedontheaforementionedpositiveeffectoftestoster-
oneoncardiaccontractilityandmusclestrength.Accordingly,rightventricular-arterialuncouplingmightcontributetothisnding.Rightventricular-pulmonaryarterialuncouplingis
Table1ClinicalcharacteristicsoftheT.O.S.CA.femalepopulationTotalfemalepopulationTDTDP-values(n=94)(n=30)(n=64)Mean¬±SDMean¬±SDMean¬±SDAge(years)66.18¬±10.2668.93¬±9.74564.89¬±10.3250.12NTproBNP(pg/ml)2597.05¬±4093.042794.47¬±3380.142504.52¬±4409.550.72
BSA(m2)1.70¬±0.161.68¬±0.11.71¬±0.190.34SBP(mmHg)123.29¬±17.8

---

### Chunk 11/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.501

onalstudies,
womenaremorelikelythanmentohaveplaque
erosionsandcoronarymicroembolization(21),spontaneouscoronaryarterydissections(22),andcoronarymicrovasculardysfunction(23),andwomenareconsistentlyunderrepresentedinclinical
trialsofcardiovasculartherapies(24‚Äì26).Womenmayalsohavebeensubjectedtoclinicianbiasintheuseofdiagnostictestsorprovisionoftherapies
(27)orhavehadadisproportionateburdenofpsy-chosocialriskfactors,suchasdepressionoralack
ofsocialsupport,whichcaninuencesubsequentcardiovascularrisk(28).Shouldinternationalguidelinesrecommendtheuseofsex-specicthresholdsforthediagnosisofmyocardialinfarction?Althoughwedidnotdirectlycompareauniform99thcentilethresholdagainstthesex-specicthresholdinthistrial,ourstudydoesprovidesomehelpfulinsightsintotheuseofsex-
specicthresholds.First,useofsex-specicthresh-oldsidentiessimilarproportionsofwomenandmenpresentingwithsuspectedacutecoronarysyndromewithmyocardialinjury.Second,womenandmen
reclassiedbythehigh-sensitivityassaywithsex-specicthre

---

### Chunk 12/30
**Article:** Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men? (2006)
**Journal:** Journal of Human Hypertension
**Section:** abstract | **Similarity:** 0.499

This prospective study examined 3,338 women and 3,330 men with hypertension over 11.2 years to assess whether ECG left ventricular hypertrophy (LVH) by Sokolow-Lyon voltage criteria predicted cardiovascular outcomes differently by gender. Increasing voltage independently predicted CVD mortality in both men and women. The risk of stroke, coronary heart disease (CHD) and cardiovascular disease (CVD) mortality increased significantly for each quantitative 0.1 mV increase in baseline ECG voltage, in women within the range of 1.6-3.9% and in men 1.4-3.0%. Women tended to have a high risk of stroke mortality owing to LVH, while men demonstrated stronger associations between voltage and coronary heart disease mortality.

---

### Chunk 13/30
**Article:** Echocardiographic Reference Ranges of Global Longitudinal Strain for All Cardiac Chambers Using Guideline-Directed Dedicated Views (2024)
**Journal:** JACC: Cardiovascular Imaging
**Section:** abstract | **Similarity:** 0.498

Estudo estabeleceu valores de refer√™ncia para strain longitudinal global de todas c√¢maras card√≠acas usando imagens obtidas conforme recomenda√ß√µes da ASE/EACVI. Incluiu 1.329 participantes saud√°veis do estudo HUNT4Echo. Valores de refer√™ncia para GLS do ventr√≠culo esquerdo: -24% a -16%. Todos os strains associaram-se com idade, e GLS ventricular esquerdo associou-se com sexo. World Alliance Societies of Echocardiography prop√¥s valores normais: -17% a -24% para homens e -18% a -26% para mulheres. Define-se GLS normal como ‚â§-18% e anormal como ‚â•-16%.

---

### Chunk 14/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** methods | **Similarity:** 0.496

dbyamoreadvanceddisease.Therefore,theaimofthecurrentstudywastoinvestigatetheprevalenceandtheclinicalandprognosticimpactofTD
onwomenaffectedbyHFrEF,particularlyfocusingonexercisecapacity,leftaswellasrightheartgeometryandfunction.MethodsStudypopulationClinicaldataoffemalepatientsenrolledwithintheT.O.S.CA.(TerapiaOrmonaleScompensoCArdiaco)wereanalysed.Studydesignandpatient‚ÄôsbaselinecharacteristicsoftheT.O.S.CA.studyhavebeenalreadydescribedelsewhere.11,12Briey,theT.O.S.CA.registryisaprospectiveandnation-wideobservationalstudyrecruitingconsecutivestableCHFpatientswithleftventricularejectionfraction
(LVEF)‚â§45%,inclinicalstabilityduring6monthsbeforeen-rolment(denedasnohistoryofrecentacutedecompensa-tionoracutecoronarysyndrome).Furtherexclusioncriteria
were(1)severelivercirrhosisinChild‚ÄìTurcotte‚ÄìPughstageBorC;(2)clinicallyrelevantkidneydisease(creatininelevel>2.5mg/dl);(3)activemalignancy;and(4)currenthormonaltreatmentorovertendocrinediseases.PatientsenrolledintheT.O.S.CA.wereallonst

---

### Chunk 15/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** results | **Similarity:** 0.495

gnostics,andSingulex.All
otherauthorshavereportedthattheyhavenorelationshipsrelevanttothecontentsofthispapertodisclose.ManuscriptreceivedJuly11,2019;revisedmanuscriptreceivedJuly25,2019,acceptedJuly28,2019.JACCVOL.74,NO.16,2019Leeetal.OCTOBER22,2019:2032‚Äì43Sex-SpecicThresholdsofhs-cTnI2033

internationalguidelinesinuseduringenrollment(9,10).Throughoutthedurationofthetrial,allsitesmeasuredcardiactroponinusingboththecTnIand
hs-cTnIassayssimultaneously.Duringthevalidation
phase,onlytheresultsofthecTnIassaywerere-portedtotheattendingclinician,whileduringtheimplementationphase,onlytheresultsofthehs-cTnIassaywerereported.ThecTnIassay(ARCHITECTSTATtroponinIassay;AbbottLaboratories,AbbottPark,Illinois)with
asinglediagnosticthresholdforwomenandmen
wasusedtoguideclinicaldecisionsduringthevali-
dationphase.Theinterassaycoefcientofvariationwas<10%at40ng/lat7sitesand50ng/lat3sites,andtheseconcentrationswereusedasthediagnostic
thresholdsduringthevalidationphase(11).Duringtheimplementationphase,a

---

### Chunk 16/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.493

ction.ClinChem2016;62:831‚Äì8.17.RubiniGimenezM,TwerenboldR,BoeddinghausJ,etal.Clinicaleffectofsex-
speciccutoffvaluesofhigh-sensitivitycardiactroponinTinsuspectedmyocardialinfarction.
JAMACardiol2016;1:912‚Äì20.
PERSPECTIVES
COMPETENCYINPATIENTCAREANDPROCEDURALSKILLS:Asex-specicthresholdlevelofhigh-sensitivitycardiactroponinidentiesahigherproportionofwomenwithmyocardialinjury
andinfarctionbutmaynotimproveclinical
outcomeswhentherearedisparitiesintreatment
implementationorefcacy.TRANSLATIONALOUTLOOK:Futurestudiesshouldfocusonimprovingaccesstoangiographicevaluationandtherapeuticinterventionsforwomenwithacutecoronarysyndromes.

---

### Chunk 17/30
**Article:** Cardiologia VIII (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.492

# Cardiologia VIII

**Source:** https://web.plaud.ai/share/43b41764908850761::YXdzOnVzLXdlc3QtMg

---

## Reasoning Summary

## An√°lise de Exames, Fatores de Risco e Estrat√©gias Terap√™uticas em Cardiologia
### 1. Interpreta√ß√£o de Exames e Marcadores de Risco Cardiovascular
- **Princ√≠pio da Probabilidade e Contexto Cl√≠nico:** A an√°lise de exames laboratoriais deve seguir o princ√≠pio de que a medicina √© uma "ci√™ncia da probabilidade". Os valores devem ser interpretados dentro do contexto cl√≠nico do paciente (hist√≥ria, exame f√≠sico, idade) e n√£o como n√∫meros isolados a serem "corrigidos". √â crucial n√£o se fixar em atingir valores "√≥timos" em todos os exames, pois o exame √© um desfecho substituto e a prioridade √© o paciente como um todo.

---

### Chunk 18/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.492

majorhealthproblemswithanowadaysestimated5yearmortalityrateof50%.1Inthisregard,thereisanurgentneedofinnovativetherapeu-ticapproachespotentiallyabletohaltdiseaseprogressionandincreasesurvival.1Notwithstanding,theoverallmagni-tudeofheartfailurewithreducedejectionfraction(HFrEF),aconsiderablelackofsex-specicdatarepresentanunmetneedofcardiovascularmedicine.2Takenalltogether,almost30%ofHFrEFpatientsarewomen3andtendtobeolderandareburdenedbyhighernumberofco-morbiditiesthanmen.4However,clinicaloutcomesofwomenwithHFrEFdonotdifferfromthoseofmalecounterpart.5Ontheotherhand,womenwithHFrEFrepresentapoorlycharacterizedsubgroupofpatients,withlittleinformationavailableinthe
currentliteratureregardingclinicalpresentation,naturalhistory,andriskfactorsforworseoutcomes.Inthisregard,amongthewholespectrumoftheHFrEFpopulation,anabolic
decienciesplayarelevantrole,beingassociatedwithin-creasedmorbidityandmortality.6,7InunselectedcohortofmenwithCHF,ithasbeendemonstratedthatreducedserum
concentrationoftestoste

---

### Chunk 19/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.492

o cr√¥nica.
    -   Lipoprote√≠na (a) elevada, um fator de risco gen√©tico pr√≥-tromb√≥tico e pr√≥-inflamat√≥rio.
    -   Desequil√≠brios hormonais (baixo estrog√™nio e testosterona), especialmente na menopausa.
-   **Diagn√≥stico Suspeito:** Nenhum no momento
## Plano:
-   **Prescri√ß√£o:** Inserir mais aqui
-   **Pr√≥ximos Passos/Exames:**
    -   O palestrante defende uma avalia√ß√£o abrangente que vai al√©m dos fatores de risco cl√°ssicos, incluindo:
    -   Dosagem das propor√ß√µes de √îmega-3 e √îmega-6 (√çndice √îmega-3).
    -   Medi√ß√£o do Horm√¥nio D (Vitamina D), com metas de n√≠veis √≥timos (ex: >80 ng/mL para cardiopatas, controlando com PTH).
    -   Curva glic√™mica e de insulina para detectar resist√™ncia √† insulina precocemente.
    -   Avalia√ß√£o da homociste√≠na.
    -   Medi√ß√£o da lipoprote√≠na (a).
    -   Avalia√ß√£o da rela√ß√£o ApoB/ApoA.
    -   Avalia√ß√£o dos n√≠veis hormonais (testosterona, estradiol, DHEA).

---

### Chunk 20/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.486

enceimmunoassay(ECLIAbyRochediagnostics)usingaRocheElecsysanalyser.Serumhormoneswereanalysedinacentralizedcore-lab(IRCCSSDN,Naples,Italy).Insulinandinsulingrowth
2A.M.Marraetal.ESCHeartFailure(2022)DOI:10.1002/ehf2.14117
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

factor-1(IGF-1)wereassayedbyanenzyme-labelledchemiluminescentimmunometricassay(IMMULITE2000;IGF-1,interassayCV=5.7%,SiemensMedicalSolutionsDiag-
nostics).DHEA-Swasmeasuredbyasolid-phase,competitivechemiluminescentenzymeimmunoassay.TotaltestosteronewasmeasuredwithaDPCCoat-A-CountRIAkit.TDwasde-
nedaccordingtocurrentguidelinesasserumtestosteronelevelslowerthan25ng/dl.13StatisticalanalysisNormallydistributedcontinuousvariableswereexpressedasmean¬±standarddeviation.Categoricalvariableswere
expressedascountsandpercentages.FemaleHFrEFpatientswerecomparedaccordingtothepresenceofTDornormaltestosteronelevels(TD)withunpairedStudent‚Äôst-test.Cat-eg

---

### Chunk 21/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.486

m DCV), condi√ß√µes gestacionais (pr√©-termo, hipertensivas, diabetes gestacional), autoimunidade, tratamento de c√¢ncer de mama e defici√™ncias hormonais (climat√©rio/menopausa), frequentemente subvalorizadas nos protocolos. O palestrante defende abordagem multidisciplinar e estruturada de estilo de vida, especialmente em hipertens√£o lim√≠trofe, apoiada por nutricionistas e educa√ß√£o para ades√£o.
O uso de estatinas √© discutido criticamente: reconhece-se benef√≠cio anti-inflamat√≥rio local no p√≥s-angioplastia (les√£o de parede e fragilidade do stent), por√©m questiona-se o uso indiscriminado, sobretudo em preven√ß√£o prim√°ria, citando meta-an√°lise que desafia a hip√≥tese lip√≠dica e alertando para vieses na interpreta√ß√£o de risco relativo vs. absoluto. Em UTI, menciona-se aumento de del√≠rio e a necessidade de evitar ‚Äúreceita de bolo‚Äù (anticoagula√ß√£o, IBP, estatina autom√°tica).

---

### Chunk 22/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.485

TDshowedlowerleveloftricuspidannularplaneexcursion(TAPSE)topulmonaryarterialsystolicpressurePASPratio(TAPSE/PASP)(0.53¬±0.22and0.68¬±0.32mm/mmHg
inTDandTD,respectively,P=0.008),whichisasurrogateparameterofrightventricular-arterialuncoupling.Furthermore,HFrEFwomenwithTDalsodisplayedmoreim-
pairedcardiopulmonaryperformanceasshownbylowervaluesofpeakoxygenconsumption(VO2peak)thanthosewithoutTD(18.89¬±4.92vs.21.31¬±4.92ml*kg1*min1P=0.03).WomenwithTDalsohadworserenalfunctionasshownbylowervaluesofeGFRascomparedwiththoseTD(54.27¬±23.02vs.75.55¬±36.76ml/min,P<0.001).ClinicaloutcomesAfterameanfollow-upof36months,atotalof54eventswererecorded,with18deathsand36cardiovascularhospi-talizations.NinewomenoftheTDgroup(30%)andninewomenoftheTDgroup(14%)diedduringfollow-up.Fif-teenwomenoftheTDgroup(50%)underwenthospitaliza-tionduetocardiovascularreasonswhereas21cardiovascularhospitalizationswererecordedintheTDgroup(32%).AsdepictedinFigure1A,TDwasassociatedwithasignicantdifferenceintheoccurrenceofthe

---

### Chunk 23/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.483

riaforhearttransplantation:A
10-yearupdate.JHeartLungTransplant.2016;35:1‚Äì23.22.HarmsCA.Doesgenderaffectpulmo-naryfunctionandexercisecapacity?
RespirPhysiolNeurobiol.2006;151:124‚Äì131.23.VonkNoordegraafA,WesterhofBE,WesterhofN.Therelationshipbetween
therightventricleanditsloadinpulmo-naryhypertension.JAmCollCardiol.2017;69:236‚Äì243.24.RichterMJ,YogeswaranA,Husain-SyedF,Vad√°szI,RakoZ,MohajeraniE,GhofraniHA,NaeijeR,SeegerW,HerbergU,RiethA,TedfordRJ,
GrimmingerF,GallH,TelloK.Anovel
non-invasiveandechocardiography-derivedmethodforquanticationofrightventricularpressure-volumeloops.

---

### Chunk 24/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.483

-specic thresholds identied 5-times moreadditional women than men with myocardial injuryDespite this, women received fewer treatmentsfor coronary artery disease than men
And their outcomes were not improved.Adjusted Hazard Ratio:Women 1.11 (95% CI: 0.92 - 1.33)Men 0.85 (95% CI: 0.71 - 1.01)Coronaryrevascularization(35% versus 57%)Dual anti-platelettherapy(54% versus 67%)Women
Men
Type 1 MIType 2 MINon-ischemicmyocardialinjury
Lee,K.K.etal.JAmCollCardiol.2019;74(16):2032‚Äì43.Sex-specicthresholdsidentied5timesmoreadditionalwomenthanmenwithmyocardialinjury.Despitethis,womenreceivedfewertreatmentsforcoronaryarterydiseasethanmen,andtheiroutcomeswerenotimproved.CI¬ºcondenceinterval;MI¬ºmyocardialinfarction.Leeetal.JACCVOL.74,NO.16,2019Sex-SpecicThresholdsofhs-cTnIOCTOBER22,2019:2032‚Äì432040

cardiovasculardeathat1year(8).Here,wereporttheprimaryoutcomestratiedbysex.Thevastmajorityofpatientsreclassiedbythesex-specicthresholdswerewomen,butwedidnotobserveanyimprove-
mentintheiroutcome

---

### Chunk 25/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.482

tion-shipinheartfailure:Anindexofright
ventricularcontractilefunctionand
prognosis.AmJPhysiolHeartCircPhys-iol.2013;305:H1373‚ÄìH1381.26.GhioS,GuazziM,ScardoviAB,KlersyC,ClemenzaF,CarluccioE,TemporelliPL,
RossiA,FaggianoP,TraversiE,VrizO,DiniFL,allinvestigators.Differentcor-relatesbutsimilarprognosticimplica-
tionsforrightventriculardysfunction
inheartfailurepatientswithreducedorpreservedejectionfraction.EurJHeartFail.2017;19:873‚Äì879.27.VentetuoloCE,OuyangP,BluemkeDA,TandriH,BarrRG,BagiellaE,CappolaAR,BristowMR,JohnsonC,KronmalRA,KizerJR,LimaJAC,KawutSM.Sexhormonesareassociatedwithrightven-
tricularstructureandfunctiontheMESA-rightventriclestudy.AmJRespirCritCareMed.2011;183:659‚Äì667.28.VentetuoloCE,PraestgaardA,PalevskyHI,KlingerJR,HalpernSD,KawutSM.Sexandhaemodynamicsinpulmonaryarterialhypertension.EurRespirJ.2014;43:523‚Äì530.29.MahonNG,BlackstoneEH,FrancisGS,StarlingRC,YoungJB,LauerMS.Theprognosticvalueofestimatedcreatinine
Testosteronedeciencyinwomenwithheartfailure7ESCHeartFa

---

### Chunk 26/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.482

theT.O.S.CA.(TerapiaOrmonaleScompensoCArdiaco)registry,aprospective,multicentre,nationwide,observationalstudy,94womenwereincludedinthecurrentanalysis.TheTDwasde-nedasserumtestosteronelevelslowerthan25ng/dl.Dataregardingclinicalstatus,echocardiography,exerciseperformance,cardiovascularhospitalization,andsurvivalafteranaveragefollow-upof36monthswereanalysed.ResultsThirtypatients(31.9%)displayedTD.TDwasassociatedwithlowertricuspidannularplaneexcursion(TAPSE)topulmonaryarterialsystolicpressurePASPratio(TAPSE/PASP)(P=0.008),peakoxygenconsumption(VO2peak)(P=0.03)andestimatedglomerularltrationrate(P<0.001).TDwasanindependentpredictorofthecombinedendpointofall-causemortality/cardiovascularhospitalization(HR:10.45;95%CI:3.54‚Äì17.01;P=0.001),all-causemortality(HR:8.33;95%:5.36‚Äì15.11;P=0.039),andcardiovascularhospitalization(HR:2.41;95%CI:1.13‚Äì4.50;P=0.02).ConclusionsOne-thirdofwomenwithHFrEFdisplaysTDthatimpactsremarkablyontheirmorbidityandmortality.TDisas-sociatedwithaworseclinicalprole

---

### Chunk 27/30
**Article:** Cardiologia VI (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.478

es com insufici√™ncia card√≠aca congestiva, conforme um estudo de 2010 com acompanhamento de 6 meses.
**A obesidade e a resist√™ncia insul√≠nica emergem como fatores de risco independentes e severos, aumentando a chance de hipertens√£o em 3,5 vezes e reduzindo a expectativa de vida em at√© 20 anos em casos de obesidade m√≥rbida.**
- Pacientes obesos com s√≠ndrome metab√≥lica apresentam um risco de mortalidade 18% maior e uma redu√ß√£o na expectativa de vida de 5 a 20 anos.
- Um estudo de 2017 mostrou que pacientes obesos com s√≠ndrome metab√≥lica t√™m 3,5 vezes mais chances de se tornarem hipertensos.
- A resist√™ncia insul√≠nica foi identificada como um fator de risco para doen√ßa cardiovascular j√° em 1996 e foi prevalente em 26% das pacientes n√£o diab√©ticas com c√¢ncer de mama em um estudo de 2012-2014 com 760 mulheres.

---

### Chunk 28/30
**Article:** EuropeanJournalofHeartFailure(2023)25,1891‚Äì1898POSITIONPAPERdoi:10.1002/ejhf.3036 (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.477

calPracticeGuidelines.JAmCollCardiol2022;79:1757‚Äì1780.https://doi.org/10.1016/j.jacc.2021.12.0114.Revuelta-L√≥pezE,BarallatJ,Cserk√≥ov√°A,G√°lvez-Mont√≥nC,JaffeAS,JanuzziJL,etal.Pre-analyticalconsiderationsinbiomarkerresearch:Focusoncardiovasculardisease.ClinChemLabMed.2021;59:1747‚Äì1760.5.Pop-BusuiR,JanuzziJL,BruemmerD,ButaliaS,GreenJB,HortonWB,etal.Heartfailure:Anunderappreciatedcomplicationofdiabetes.Aconsensusreportofthe
AmericanDiabetesAssociation.DiabetesCare2022;45:1670‚Äì1690.https://doi.org/10.2337/dci22-00146.BozkurtB,CoatsAJS,TsutsuiH,AbdelhamidCM,AdamopoulosS,AlbertN,etal.Universaldenitionandclassicationofheartfailure:AreportoftheHeartFailureSocietyofAmerica,HeartFailureAssociationoftheEuropean
SocietyofCardiology,JapaneseHeartFailureSocietyandWritingCommittee
oftheUniversalDenitionofHeartFailure:EndorsedbytheCanadianHeart
FailureSociety,HeartFailureAssociationofIndia,CardiacSocietyofAustralia
andNewZealand,andChineseHeartFailureAssociation.EurJHeartFail2021;23:352‚Äì

---

### Chunk 29/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** introduction | **Similarity:** 0.476

Sex-SpecicThresholdsofHigh-SensitivityTroponininPatientsWith
SuspectedAcuteCoronarySyndromeKuanKenLee,MD,a,*AmyV.Ferry,BSC,a,*AtulAnand,MD,aFionaE.Strachan,PHD,aAndrewR.Chapman,MD,aDorienM.Kimenai,PHD,b,cStevenJ.R.Meex,PHD,b,cColinBerry,MD,dIainFindlay,MD,eAlanReid,MSC,fAnneCruickshank,MD,fAlasdairGray,MD,gPaulO.Collinson,MD,hFredS.Apple,PHD,iDavidA.McAllister,MD,jDonoghMaguire,MD,kKeithA.A.Fox,MBCHB,aDavidE.Newby,MD,aChrisTuck,BSC,lCatrionaKeerie,MSC,lChristopherJ.Weir,PHD,lAnoopS.V.Shah,MD,a,m,yNicholasL.Mills,MD,a,m,yonbehalfoftheHigh-STEACSInvestigatorsABSTRACTBACKGROUND
Majordisparitiesbetweenwomenandmeninthediagnosis,management,andoutcomesofacutecoronarysyndromearewellrecognized.
OBJECTIVES
Theaimofthisstudywastoevaluatetheimpactofimplementingahigh-sensitivitycardiactroponinIassaywithsex-specicdiagnosticthresholdsformyocardialinfarctioninwomenandmenwithsuspectedacutecoronarysyndrome.

---

### Chunk 30/30
**Article:** EuropeanJournalofHeartFailure(2023)25,1891‚Äì1898POSITIONPAPERdoi:10.1002/ejhf.3036 (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.476

herauthorshavenothing
todisclose.References1.McDonaghTA,MetraM,AdamoM,GardnerRS,BaumbachA,B√∂hmM,etal.;ESCScienticDocumentGroup.2021ESCGuidelinesforthediagnosisandtreatmentofacuteandchronicheartfailure:DevelopedbytheTaskForcefor
thediagnosisandtreatmentofacuteandchronicheartfailureoftheEuropean
SocietyofCardiology(ESC).WiththespecialcontributionoftheHeartFailure
Association(HFA)oftheESC.EurJHeartFail2022;24:4‚Äì131.https://doi.org/10.1002/ejhf.23332.Guidelinesforthediagnosisofheartfailure.TheTaskForceonHeartFailureoftheEuropeanSocietyofCardiology.EurHeartJ1995;16:741‚Äì751.3.HeidenreichPA,BozkurtB,AguilarD,AllenLA,ByunJJ,ColvinMM,etal.AHA/ACC/HFSAGuidelineforthemanagementofheartfailure:Executive
summary:AreportoftheAmericanCollegeofCardiology/AmericanHeart
AssociationJointCommitteeonClinicalPracticeGuidelines.JAmCollCardiol2022;79:1757‚Äì1780.https://doi.org/10.1016/j.jacc.2021.12.0114.Revuelta-L√≥pezE,BarallatJ,Cserk√≥ov√°A,G√°lvez-Mont√≥nC,JaffeAS,JanuzziJL,etal.Pre-analyticalconsid

---

